(19)
(11) EP 3 549 543 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.08.2023 Bulletin 2023/34

(45) Mention of the grant of the patent:
19.07.2023 Bulletin 2023/29

(21) Application number: 19159707.9

(22) Date of filing: 13.06.2012
(51) International Patent Classification (IPC): 
A61B 18/12(2006.01)
A61B 18/00(2006.01)
A61B 18/14(2006.01)
A61B 18/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 18/16; A61B 2018/00327; A61B 2018/00702; A61B 2018/00821; A61B 2018/00922; A61B 2018/00005; A61B 2018/00023; A61B 2018/143; F04C 2270/041; A61B 18/14; A61B 2017/248; A61B 2018/00708; A61B 2017/320069; A61B 2017/32007; A61B 18/1815; A61B 18/20; A61B 2018/00577; A61B 2018/1807; A61B 2018/1861; A61F 5/08; A61B 18/1485; A61B 18/1442; A61B 18/02; A61B 2018/00595; A61B 2018/00642; A61B 2018/00875; A61B 2018/0212; A61B 2018/0225; A61B 2018/1253; A61B 2018/126; A61B 18/1206; A61B 18/1477; A61B 2018/00791; A61B 2018/00886; A61F 5/56; A61N 5/025; A61N 5/0603; A61N 5/0625; A61B 17/320068

(54)

DEVICE FOR TREATING NASAL AIRWAYS

VORRICHTUNG ZUR BEHANDLUNG DER NASALEN ATEMWEGE

DISPOSITIF DE TRAITEMENT DE VOIES NASALES


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 14.06.2011 US 201161496930 P
27.02.2012 US 201261603864 P

(43) Date of publication of application:
09.10.2019 Bulletin 2019/41

(60) Divisional application:
23177809.3

(62) Application number of the earlier application in accordance with Art. 76 EPC:
12728929.6 / 2720632

(73) Proprietor: Aerin Medical, Inc.
Mountain View, CA 94043 (US)

(72) Inventors:
  • WOLF, Scott J.
    Menlo Park, CA 94025 (US)
  • FRAZIER, Andrew
    Sunnyvale, CA 94087 (US)

(74) Representative: IK-IP LTD 
3 Lloyd's Avenue
London, Greater London EC3N 3DS
London, Greater London EC3N 3DS (GB)


(56) References cited: : 
WO-A1-2010/077980
US-A1- 2002 016 588
US-A1- 2004 220 644
US-A1- 2006 235 377
US-A1- 2010 174 283
US-A- 6 096 033
US-A1- 2003 225 403
US-A1- 2005 234 439
US-A1- 2007 073 282
US-A1- 2012 078 377
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).